Primary Intraocular Lymphoma
2 clinical trials · Condition
◉ Watch Primary Intraocular Lymphoma
| Record | Firm | Date |
|---|---|---|
| ZR-MTX for PIOL Phase II Trial (NCT06973811) | Peking Union Medical College Hospital | 2025-05-21 |
| Intravitreal Methotrexate and R2(Rituximab & Lenalidomide) Regimen in Newly-diagnosed Primary Vitreoretinal Lymphoma (NCT03746223) | Peking Union Medical College Hospital | 2018-11-15 |
Track Primary Intraocular Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.